Gilead Sciences Ranks 49th in Trading Volume with $1.13 Billion as Stock Surges 10.91% in Four Days

On May 20, 2025, Gilead Sciences (GILD) saw a trading volume of $1.13 billion, ranking 49th in the day's stock market activity. The stock rose by 2.78%, marking its fourth consecutive day of gains, with a total increase of 10.91% over the past four days.

Recent transactions by institutional investors indicate a bullish outlook for Gilead Sciences. Despite the current political environment, there is growing positive sentiment surrounding GILD stock.

Tomas Cihlar, Senior Vice President of Research, Virology at Gilead Sciences, has been named to TIME's list of the 100 Most Influential People in the World for his groundbreaking HIV research and development. This recognition highlights the significant progress made by Gilead in its efforts to combat the HIV epidemic globally.